Niagen Bioscience, Inc. · NASDAQ:NAGE
Fried Robert N received 1,106 Niagen Bioscience, Inc. shares as an award (Form 4)
Traded Jun 30, 2026 · Filed Jul 8, 2026
On Jun 30, 2026, Fried Robert N (Director, Chief Executive Officer) received 1,106 Niagen Bioscience, Inc. shares as an award at US$2.71 for US$2,997, leaving 1,060,087 shares. Filed Jul 8, 2026 (Form 4).
- Awarded
- 1,106 shares
- Price
- US$2.71
- Value
- US$2,997
- Holding after
- 1,060,087 shares
- Trading plan
- No
- Role
- Director, Chief Executive Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 30, 2026 | Common Stock | Award | 1,106 | US$2.71 | 1,060,087 | Direct |
Source
Related
- Niagen Bioscience, Inc.
- Fried Robert N
- Niagen Bioscience, Inc. shareholders
- Form 4 · Fried Robert N · Apr 27, 2026
- Schedule 13G · BlackRock, Inc. · Jul 29, 2026
- Form 4 · Lopez Carlos Luis · Jul 8, 2026
- Form 4 · Pamir Ozan · Jul 8, 2026
- Schedule 13G/A · The Vanguard Group · Jan 30, 2026
- Schedule 13G · The Vanguard Group · Oct 31, 2025